Bio-Techne, a pharmaceutical company based in Minnesota, is a leading life sciences manufacturer providing consumables and instruments for the pharma, biotech, academic, and diagnostic markets. With a medium-risk ESG score of 25.8, Bio-Techne operates in two segments: protein sciences and diagnostics and genomics. The company's products are used in life sciences research, including antibodies for protein analysis. While the United States contributes about 55% of revenue, Bio-Techne also has operations in Europe, the Middle East, Africa, the UK, and Asia-Pacific. Explore Bio-Techne's innovative solutions for the pharmaceutical industry.